Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-06 Option Award | 2024-06-10 4:20 pm | 2025-06-06 2034-06-06 | Akebia Therapeutics Inc. | AKBA | Wolf Myles Director | 75,000 | $0 | 142,681 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:07 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | Wolf Myles Director | 75,000 | $0 | 112,681 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 5:00 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | Wolf Myles Director | 33,800 | $0 | 57,781 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-03 5:28 pm | 2022-06-02 2031-06-02 | Akebia Therapeutics Inc. | AKBA | Wolf Myles Director | 33,800 | $0 | 44,081 (Direct) | View |
| 2020-04-06 Option Award | 2020-04-07 08:31 am | N/A 2030-04-06 | Akebia Therapeutics Inc. | AKBA | Wolf Myles Director | 80,200 | $0 | 80,200 (Direct) | View |
Ownership | 2020-04-07 08:30 am | N/A N/A | Akebia Therapeutics Inc. | AKBA | Wolf Myles Director | 0 | $0 | 10,281 (Direct) | View |